GCTK - Company ID 0001506983
The table below shows GlucoTrack, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $9.81M | $9.50M | $4.70M | $1.97M | $1.81M | $1.53M |
| SG&A | $6.28M |
GlucoTrack, Inc. reported annual revenue of $208.00K for fiscal year 2019. That is down 100.0% from $17.00B in fiscal 2018. Over the 6 fiscal years shown, annual revenue grew from $59.77K (FY 2014) to $208.00K. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $5.05M |
| $2.28M |
| $2.46M |
| $139.00K |
| $415.00K |
| Operating income | -$16.09M | -$14.55M | -$7.10M | -$4.43M | -$4.04M | -$3.13M |
| Income tax | - | - | - | - | - | - |
| Net income | -$19.39M | -$22.60M | -$7.10M | -$4.43M | -$4.07M | -$2.70M |
| EPS (diluted) | $31.22 | $4.11K | $34.18 | $0.29 | $0.26 | $0.19 |